This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Mikie Kambara: Innovator in Pharmaceutical Chemistry
Introduction
Mikie Kambara is a notable inventor based in Azumino, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target sex hormone-dependent diseases. Her innovative work has led to the creation of a unique nitrogenated fused ring derivative.
Latest Patents
Kambara holds a patent for a nitrogenated fused ring derivative, which is described as a pharmaceutical composition comprising the same. This invention is aimed at providing agents for the prevention or treatment of sex hormone-dependent diseases. The patent outlines the general formula of the compounds, which exhibit GnRH antagonistic activity, along with their medicinal uses.
Career Highlights
Mikie Kambara is associated with Kissei Pharmaceutical Co., Ltd., where she has been instrumental in advancing pharmaceutical research. Her work has not only contributed to the scientific community but has also paved the way for new therapeutic options in medicine.
Collaborations
Kambara has collaborated with esteemed colleagues such as Shigeru Yonekubo and Takashi Miyagi. These partnerships have enhanced her research and development efforts, leading to innovative solutions in the pharmaceutical industry.
Conclusion
Mikie Kambara's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. Her patent for a nitrogenated fused ring derivative showcases her commitment to addressing critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile